Karyopharm Therapeutics Inc. (KPTIQ) stock
KPTIQOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as KPTI
Share price
Not available yet
Price, market cap and P/E appear here once daily prices are connected.
Karyopharm Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Karyopharm Therapeutics's price to sales ratio was 0.0× on Nov 9, 2026, against 0.3× a year earlier. Over the last 5 years it ranged from 0.0× to 5.7×, with a median of 0.8×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 9, 2026 | 0.0× | −0.4 |
| 2025 | Dec 31, 2025 | 0.4× | −0.1 |
| 2024 | Dec 31, 2024 | 0.6× | −0.1 |
| 2023 | Dec 29, 2023 | 0.7× | −0.4 |
| 2022 | Dec 30, 2022 | 1.1× | −3.0 |
| 2021 | Dec 31, 2021 | 4.1× | −8.4 |
| 2020 | Dec 31, 2020 | 12.5× | −39.8 |
| 2019 | Dec 31, 2019 | 52.3× | +34.3 |
| 2018 | Dec 31, 2018 | 18.0× | −208.8 |
| 2014 | Jan 31, 2014 | 226.7× | +77.9 |
| 2013 | Dec 31, 2013 | 148.9× | – |
See a number that looks wrong?